一例罕见的老年丙型肝炎患者纤维层状肝细胞癌获得持续病毒学应答。

IF 1.7 4区 医学 Q4 ONCOLOGY
Hiroyuki Komori, Toshiro Masuda, Ryoichi Kurano, Hiroki Sugita, Fumimasa Kitamura, Rumiko Tashima, Shinobu Honda, Seiji Mita, Yasunori Nagayama, Toru Beppu
{"title":"一例罕见的老年丙型肝炎患者纤维层状肝细胞癌获得持续病毒学应答。","authors":"Hiroyuki Komori, Toshiro Masuda, Ryoichi Kurano, Hiroki Sugita, Fumimasa Kitamura, Rumiko Tashima, Shinobu Honda, Seiji Mita, Yasunori Nagayama, Toru Beppu","doi":"10.21873/anticanres.17762","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare histological variant of hepatocellular carcinoma (HCC) that typically affects adolescents and young adults without underlying liver disease. In elderly patients, particularly those with a history of chronic hepatitis C virus (HCV) infection, FLHCC is extremely rare and presents diagnostic challenges.</p><p><strong>Case report: </strong>A 67-year-old woman with a history of chronic HCV infection and sustained virologic response (SVR) was incidentally found to have two hepatic lesions during routine follow-up imaging. Contrast-enhanced studies revealed early arterial enhancement and delayed washout, suggestive of conventional HCC. She underwent open segmentectomy of segment 7 and radiofrequency ablation (RFA) of the segment 4/8 lesion. Histopathological examination of the resected specimen confirmed the diagnosis of FLHCC. The patient experienced three recurrences, treated with two laparoscopic RFAs and one open systematic liver resection. The third recurrence was histologically confirmed as FLHCC. Although the ablated lesions were not biopsied, the clinical course and tumor marker trends supported a diagnosis of metastatic and multicentric FLHCC. The patient subsequently received two sessions of transarterial chemoembolization. At seven years and two months after the initial surgery, she remains alive with disease and maintains a performance status of 0.</p><p><strong>Conclusion: </strong>We report an extremely rare case of FLHCC in an elderly patient with a history of HCV infection and SVR. Long-term disease control was achieved through multidisciplinary treatment centered on surgical resection and RFA. Surgical pathology and local ablation play important roles in managing recurrent disease.</p>","PeriodicalId":8072,"journal":{"name":"Anticancer research","volume":"45 9","pages":"4047-4055"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Rare Case of Fibrolamellar Hepatocellular Carcinoma in an Elderly Patient With Prior Hepatitis C Achieving Sustained Virologic Response.\",\"authors\":\"Hiroyuki Komori, Toshiro Masuda, Ryoichi Kurano, Hiroki Sugita, Fumimasa Kitamura, Rumiko Tashima, Shinobu Honda, Seiji Mita, Yasunori Nagayama, Toru Beppu\",\"doi\":\"10.21873/anticanres.17762\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare histological variant of hepatocellular carcinoma (HCC) that typically affects adolescents and young adults without underlying liver disease. In elderly patients, particularly those with a history of chronic hepatitis C virus (HCV) infection, FLHCC is extremely rare and presents diagnostic challenges.</p><p><strong>Case report: </strong>A 67-year-old woman with a history of chronic HCV infection and sustained virologic response (SVR) was incidentally found to have two hepatic lesions during routine follow-up imaging. Contrast-enhanced studies revealed early arterial enhancement and delayed washout, suggestive of conventional HCC. She underwent open segmentectomy of segment 7 and radiofrequency ablation (RFA) of the segment 4/8 lesion. Histopathological examination of the resected specimen confirmed the diagnosis of FLHCC. The patient experienced three recurrences, treated with two laparoscopic RFAs and one open systematic liver resection. The third recurrence was histologically confirmed as FLHCC. Although the ablated lesions were not biopsied, the clinical course and tumor marker trends supported a diagnosis of metastatic and multicentric FLHCC. The patient subsequently received two sessions of transarterial chemoembolization. At seven years and two months after the initial surgery, she remains alive with disease and maintains a performance status of 0.</p><p><strong>Conclusion: </strong>We report an extremely rare case of FLHCC in an elderly patient with a history of HCV infection and SVR. Long-term disease control was achieved through multidisciplinary treatment centered on surgical resection and RFA. Surgical pathology and local ablation play important roles in managing recurrent disease.</p>\",\"PeriodicalId\":8072,\"journal\":{\"name\":\"Anticancer research\",\"volume\":\"45 9\",\"pages\":\"4047-4055\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anticancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/anticanres.17762\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anticancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/anticanres.17762","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:纤维层状肝细胞癌(FLHCC)是一种罕见的肝细胞癌(HCC)的组织学变异,通常发生在没有潜在肝脏疾病的青少年和青壮年。在老年患者中,特别是那些有慢性丙型肝炎病毒(HCV)感染史的患者,FLHCC极为罕见,并给诊断带来挑战。病例报告:一名67岁女性,有慢性HCV感染史和持续病毒学反应(SVR),在常规随访影像中偶然发现有两个肝脏病变。对比增强研究显示早期动脉强化和延迟洗脱,提示常规HCC。她接受了7节段开放式切除术和4/8节段病变的射频消融(RFA)。切除标本的组织病理学检查证实了FLHCC的诊断。患者经历了三次复发,接受了两次腹腔镜rfa和一次开放式系统肝切除术。第三次复发经组织学证实为FLHCC。虽然消融的病变没有进行活检,但临床病程和肿瘤标志物趋势支持转移性和多中心FLHCC的诊断。患者随后接受了两次经动脉化疗栓塞。在初次手术后7年零2个月,患者仍然存活,并保持0。结论:我们报告了一例极其罕见的伴有HCV感染和SVR病史的老年FLHCC患者。通过以手术切除和射频消融术为中心的多学科治疗,实现了疾病的长期控制。手术病理和局部消融在治疗复发性疾病中起着重要作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Rare Case of Fibrolamellar Hepatocellular Carcinoma in an Elderly Patient With Prior Hepatitis C Achieving Sustained Virologic Response.

Background/aim: Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare histological variant of hepatocellular carcinoma (HCC) that typically affects adolescents and young adults without underlying liver disease. In elderly patients, particularly those with a history of chronic hepatitis C virus (HCV) infection, FLHCC is extremely rare and presents diagnostic challenges.

Case report: A 67-year-old woman with a history of chronic HCV infection and sustained virologic response (SVR) was incidentally found to have two hepatic lesions during routine follow-up imaging. Contrast-enhanced studies revealed early arterial enhancement and delayed washout, suggestive of conventional HCC. She underwent open segmentectomy of segment 7 and radiofrequency ablation (RFA) of the segment 4/8 lesion. Histopathological examination of the resected specimen confirmed the diagnosis of FLHCC. The patient experienced three recurrences, treated with two laparoscopic RFAs and one open systematic liver resection. The third recurrence was histologically confirmed as FLHCC. Although the ablated lesions were not biopsied, the clinical course and tumor marker trends supported a diagnosis of metastatic and multicentric FLHCC. The patient subsequently received two sessions of transarterial chemoembolization. At seven years and two months after the initial surgery, she remains alive with disease and maintains a performance status of 0.

Conclusion: We report an extremely rare case of FLHCC in an elderly patient with a history of HCV infection and SVR. Long-term disease control was achieved through multidisciplinary treatment centered on surgical resection and RFA. Surgical pathology and local ablation play important roles in managing recurrent disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Anticancer research
Anticancer research 医学-肿瘤学
CiteScore
3.70
自引率
10.00%
发文量
566
审稿时长
2 months
期刊介绍: ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed. ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies). Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信